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Summary.-To investigate the association between medullary carcinoma of the
thyroid (MCT) and carcinoembryonic antigen (CEA), we assayed 78 sera from
patients with thyroid diseases for CEA, employing the radioimmunoassay of double
antibody technique. All 13 sera from patients with MCT had high levels of CEA,
ranging from 14 to 170 ng/ml. Increased serum CEA was noted .even in cases of
small, localized carcinoma. By contrast, serum CEA levels were normal (below
10 ng/ml) in all other histological types of thyroid carcinoma (33 cases), except for
one case of papillary adenocarcinoma. In 32 patients with non-malignant thyroid
diseases, with few exceptions serum CEA levels remained within the normal range.
The elevated serum levels of CEA in MCT returned to normal after successful
operation. Furthermore, very high tissue concentrations ofCEA were demonstrated
in MCT. The results indicate that CEA is actively produced by MCT, and that its
measurement is useful in the diagnosis and management of the disease. It is
suggested that the highly specific association of CEA with MCT may well be related
to a defect of neural crest origin.
MEDULLARY carcinoma of the thyroid
(MCT) is known to secrete various bio-
active substances such as calcitonin,
serotonin, histaminase, etc., the unusual
properties of which are exploited to
establish early diagnosis in high-risk
individuals and also to monitor the
presence of metastatic disease following
surgical treatment (Melvin, Tashjian and
Miller, 1972). On the other hand, carcino-
embryonic antigen (CEA), which was
first found in colorectal carcinoma by
Gold and Freedman (1965), is now con-
sidered to be a tumour-associated foetal
antigen lacking specificity for particular
tissues (Dykes and King, 1972; Laurence
and Neville, 1972a). This paper describes
the presence of CEA at high concentra-
tions in sera and tumour tissues ofMCT in
contrast with other histological types of
thyroid carcinoma.
MATERIALS AND METHODS
Seventy-eight sera were obtained from
patients with thyroid disease at the Thyroid
Clinic of the Departments of Internal Medi-
cine II and Radiology, Kyoto University
Hospital. In all patients a definite diagnosis
had been made by histological examination
together with routine tests of thyroid
function including scintigraphy. Blood
samples were withdrawn by venepuncture,
and the serum separated shortly thereafter
was stored at -20°C until use.
Radioimmunoassay
The assay method employed was the
double antibody technique of nonequili-
brium system, modified from the methods
of Egan et al. (1972) and Laurence et al.
(1972b). One hundred ,ul of serum sample
was mixed with 100 ,ul of 5% normal rabbit
serum in phosphate-buffered saline (PBS) at
pH 7-4 and then with 100 ,ul of anti-CEA
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antiserum diluted 1: 12,000. The mixture
was incubated at 37°C for 2 h, and then
100 pul of 1251-CEA solution (60,000 ct/min)
wN-as added. After further incubation at 4°C
overnight, 100 pu of 300' goat anti-rabbit
IgG antiserum in PBS was also added,
followed by incubation at 37°C for another
2 h. The mixture was centrifuged at 3000
rev/min for 30 min, and the radioactivity of
the precipitate measured to estimate the
amount of CEA it contained. The assay was
run in duplicate, and was capable of deter-
mining CEA in amounts from 4 to 250 ng/ml
with a standard deviation of + 1 ng/ml for
a mean value of 15 ng/ml. The upper limit
of the normal range is 10 ng/ml. The values
obtained (Y) were linearly proportional to
those by the zirconyl phosphate gel assay (X),
as expressed by a regression equation of
Y = 0*99X + 1-53.
Purified CEA was prepared from per-
chloric acid extracts of colonic adenocarci-
noma using sequential gel filtration on
Sepharose 4B and Sephadex G-200 followed
by preparative disc-gel electrophoresis
(Hamada, Ishikawa and Yoshii, 1976). The
preparations obtained were immunologically
indistinguishable from that of Gold (kindly
supplied by Dr P. Gold). The CEA was
labelled wNith 1251 bythechloramine T method.
Specific anti-CEA antiserum was prepared
after the method of Gold and Freedman
(1965) by immunizing rabbits with perchloric
acid extracts of the tumour, followed by
absorption with normal sera and tissue ex-
tracts of colon, lung and liver.
RESULTS
Serum levels and positivities of CEA
in various types of thyroid carcinoma are
shown in Fig. 1 and Table I. All 13
patients with medullary carcinoma of the
thyroid (MCT) showed high levels of CEA,
averaging 84 ng/ml. The values in 8
patients with metastases ranged from 14
to 170 ng/ml, averaging 97 ng/ml, while
those in 5 patients without metastasis
ranged from 48 to 125 ng/ml, averaging
73 ng/ml.
By contrast, all 33 patients with other
histological types of thyroid carcinoma
showed normal levels of CEA except for
one case of papillary adenocarcinoma.
In these diseases serum CEA remained
within the normal range despite the
presence of distant metastases.
Serum CEA levels and positivities in
patients with nonmalignant thyroid dis-
eases are shown in Fig. 2 and Table I.
Only one of 9 patients with adenoma
showed a CEA level of 19 ng/ml, and
one of 7 patients with chronic thyroiditis
showed a marginally elevated value (12
ng/ml). In all 14 patients with hyper-
thyroidism and 2 with thyroid cysts, the
levels remained within the normal range.
Shown in Table II are changes in
serum levels before and after surgical
treatment of MCT. Although all CEA
levels fell postoperatively, the values
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FIG. 1. Serum CEA levels ill various types of thyroid carcinoma. In medullary carciiiorna,
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TABLE I. Carcinoembryonic Antigen in Thyroid Diseases
Medullary carcinioma
Papillary adenocarcinoma
Papillo-follicular adenocarcinoma
Follicular adenocarcinorna
Undifferentiated carcinoma
Adenoma
Cyst
Grave's disease
Hashimoto's thyroiditis
No. of
patients
13
15
8
6
4
9
2
14
7
Positive
13
1
0
0
0
0
1
Metastasis
+ - TUnknown
9 4 0
5 5 5
.3 3 2
2 1 3
4 0 0
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FIG. 2. Serum CEA levels in non-malignant (liseases of the thyroidl.
TABLE II. Preoperative and Postoperative
Values for Serum, CEA Levels in MCT
Preoperative Postoperative* Mlode of
Case (ng/ml) (ng/ml) operation
l 48 6 Radical
2 80 22 Radical
:. 88 35 Palliative
4 145 60 Palliative
5 170 130 Palliative
* The specimens were taken 5-14 months after
operation.
remained abnormally elevated in the cases
ofincomplete resection. After apparently
radical operation, the serum CEA level
returned to normal in one patient, but it
was still slightly elevated in another
patient requiring a follow-up.
Tissue concentrations of CEA were
determined in 4 cases ofMCT. The values
ranged from 26 to 105 ,ug/g wet tissue,
averaging 64 ,ug/g, and represented 104-
420 times that of hyperthyroidism.
DISCUSSION
Although positive CEA findings
initially appeared to be specific for malig-
nancies of the gastrointestinal system
(Thomson etal., 1969), subsequent studies,
employing more sensitive techniques of
radioimmunoassay, showed that serum
CEA increases in a variety ofmalignancies,
ranging from pulmonary to genito-urinary
systems and also in inflammatory bowel
diseases (Dykes and King, 1972; Laurence
et al., 1972a,b; Booth et al., 1973; Hansen
et al., 1974). It is now accepted, however,
that the assay of serum CEA is most
useful in the diagnosis of carcinoma of the
gastrointestinal tract, pancreas and bron-
chus, because positive CEA findings are
obtained in 70-900o of these diseases. It
also appears valuable in the assessment of
neuroblastoma and possibly of testicular
and mammary neoplasms, since the CEA
levels were elevated in all 6 patients with
active neuroblastoma (Reynoso et al.,
1972) and in about half the patients with
the other 2 diseases (Dykes and King,
1972; Laurence and Neville, 1972a).
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However, its estimation is thought to be
of little value in the diagnosis of tumours
in other tissues.
Early sporadic studies on thyroid
diseases showed that a positive CEA
result was found in only one out of 9
patients with thyroid carcinoma but in
none of 8 patients with adenoma or
nodular goitre (Laurence et al., 1972b;
Reynoso et al., 1972; Booth et al., 1973).
Quite recently Rochman et al. (1975)
reported a more frequent elevation of
CEA in their series including 37 patients
with thyroid carcinoma, but the positivity
was statistically significant only in cases
with no previous history of childhood
irradiation. In addition, no relationship
was noted between levels of CEA and
spread or histological appearance of the
tumour.
However, the present study has re-
vealed a highly specific association of
raised CEA levels with MCT. The posi-
tivity obtained is much higher than in
gastrointestinal malignancies and is com-
parable with that in neuroblastoma.
Furthermore, the serum levels were in
excess of 40 ng/ml in the majority (92%)
of patients including those with localized
disease. The levels are even greater than
those incarcinomata ofthe gastrointestinal
tract, bronchus and breast, in which
serum CEA above this level is seen in
only 12-13% of early and localized
lesions and in 56-77% of distant meta-
stases (Laurence et al., 1 972b; Booth et al.,
1973). It may be ascribed to the high
content of CEA in the tumour cells and
also to abundant blood supply to the
endocrine organ. The results indicate
that the assay ofCEA is very useful in the
diagnosis and follow-up of MCT.
In other histological types of thyroid
carcinoma studied by us, serum CEA has
remained mostly within the normal range,
the findings being similar to those pre-
viously reported. It is likely, therefore,
that the previous studies may include few
or no cases ofMCT, the incidence ofwhich
is 5-10% of thyroid carcinoma (Melvin
et al., 1972).
With few exceptions, h-igh CEA levels
were detected in MCT, which originates
from the parafollicular cell. Interestingly
enough, this cell is thought to be of
neural crest origin and hence differs in its
embryological derivation from the other
parenchymal cells of the thyroid gland
(Pearce, 1968; Weichert, 1970). Further-
more, it was reported that neuroblastoma,
another neural crest tumour, showed a
positive CEA finding in nearly all cases,
and that the mean value was 4-5 ng/ml in
the active disease as compared to the
normal range of less than 2 5 ng/ml
(Reynoso et al., 1972). The lower level
of CEA in the latter condition may well
be due to a less rich blood supply to the
tissue. It is therefore suggested that the
highly specific association of raised CEA
in the 2 neoplasmas may be related to a
defect ofneuroectodermal origin, although
further studies should be performed with
other neural crest tumours.
We are indebted to Dr Phil Gold,
Montreal General Hospital, Montreal, for
his generous supply of reference CEA and
his kind advice in preparing CEA and
anti-CEA antiserum, to Prof. Kanji Tori-
zuka for his continuous encouragement,
and to Dr Rikushi Morita for his kindness
in supplying patient material.
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